Ranking the Harm of Alcohol, Tobacco and Illicit Drugs for the Individual and the Population

van Amsterdam, Jan, Opperhuizen, Antoon, Koeter, Maarten, van den Brink, Wim·2010·European Addiction Research

Cited by (191)

Items 101–191 of 191

  1. (De)criminalisation of psychedelics in the Czech Republic—Where are we heading in drug policy and legislation?
    Tereza Dleštíková · 2022 · International Journal of Drug Policy
  2. Acute and chronic adverse reaction of anabolic–androgenic steroids
    Jan van Amsterdam, Fred Hartgens · 2014 · Adverse Drug Reaction Bulletin
  3. Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies
    Veljko Dubljević · 2018 · Frontiers in Pharmacology
  4. Abwägung von Nutzen und Schädlichkeit von berauschenden und schmerzlindernden Substanzen aus der Perspektive von deutschen Suchtmedizinern
    Udo Bonnet, Michael Specka, Michael Soyka, Thomas Alberti, Stefan Bender, Jörg Hilger, Thomas Hillemacher, Thomas Kuhlmann, Jens Kuhn, Christel Lüdecke et al. · 2021 · Fortschritte der Neurologie · Psychiatrie
  5. Measurement and Design Challenges in the Study of Drugs and Society
    Eric L. Sevigny, Brian Fuleihan · 2015
  6. Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates
    Udo Bonnet, Michael Specka, Ann-Kristin Kanti, Norbert Scherbaum · 2022 · Frontiers in Psychiatry
  7. Examining the Gateway Hypothesis and Mapping Substance Use Pathways on Social Media: Machine Learning Approach
    Yunhao Yuan, Erin M. Kasson, Jordan Taylor, Patricia A. Cavazos‐Rehg, Munmun De Choudhury, Talayeh Aledavood · 2024 · JMIR Formative Research
  8. Updated Indicators to Evaluate Harmful Drug Use, in Particular, Poly-Drug Use
    Emanuela Colasante, Francesco Fabi, Carla Riva Rossi, Gianpaolo Scalia Tomba, Sabrina Molinaro · 2018 · Current Drug Research Reviews
  9. New indicators of health among adolescent drug users and evaluation of drug policies comparing countries
    Elena Ventura, Harrison +Wagner, Carla Riva Rossi · 2022 · Epidemiology Biostatistics and Public Health
  10. New indicators of illegal drug use to compare drug user populations for policy evaluation
    Francesco Fabi, Alessia Mammone, Carla Rossi · 2022 · Epidemiology Biostatistics and Public Health
  11. New indicators to compare and evaluate harmful drug use among adolescents in 38 European countries
    Alessia Mammone, Francesco Fabi, Emanuela Colasante, Valeria Siciliano, Sabrina Molinaro, Ludwig Kraus, Carla Riva Rossi · 2014 · Nordic Studies on Alcohol and Drugs
  12. Wearable chemical sensors in forensic science: Advances and perspectives
    Tongfei Gao, Wenge Tang, Yangyang Liu, Zhuangzhuang Dong, Zhen Tong, Xiantao Shen, Chuixiu Huang, Yanan Wang · 2025 · TrAC Trends in Analytical Chemistry
  13. Toward a positive psychology of psychoactive drug use
    Kevin O. St. Arnaud · 2021 · Drugs Education Prevention and Policy
  14. Pharmacies as potential providers of harm reduction services: A preliminary online survey
    Edward James, Thomas L Robertshaw, Andrew D. Westwell, Andrew Paul Smith · 2018 · Drug Science Policy and Law
  15. Use characteristics and harm potential of ecstasy in The Netherlands
    Jan van Amsterdam, Johannes Gerardus Ramaekers, Ton Nabben, Wim van den Brink · 2020 · Drugs Education Prevention and Policy
  16. “He was Drugged up on Something...” Portrayals of Drugs and Violence on Crime Scene Investigation (CSI) as System Justification
    Tracy Sohoni, Julie Snell, Elizabeth Harden · 2021 · Journal of Drug Issues
  17. Psilocybin and magic mushrooms: Patterns of abuse and consequences of recreational misuse
    Andreia Machado Brito-da-Costa, Diana Dias da Silva, Áurea Madureira-Carvalho, Ricardo Jorge Dinis‐Oliveira · 2022 · Springer eBooks
  18. Pharmacotherapy for Cocaine Use Disorders
    Boris B. Quednow, Etna Engeli, Marcus Herdener · 2022 · Springer eBooks
  19. Substance Abuse in the Czech Population
    Ivana Olecká, Jiří Pospíšil · 2022
  20. Which policy for new psychoactive drugs?
    Ambros Uchtenhagen · 2016 · Addiction
  21. Chromatography for detection of illicit drugs
    Sayan Ganguly · 2025 · Elsevier eBooks
  22. Metal oxides in drug detection: Material innovations in electrochemical sensor development
    Khalid A. Alkhuzai, Abdulrahman T. Ahmed, Mohammad Ridha, R. Hannah Jessie Rani, Byomakesh Dash, Hussein Riyadh Abdul Kareem Al‐Hetty, Shaik Dariyabi, Alisha Vashisht, Zainab Jamal Hamoodah, Basim Mohammed Saadi · 2025 · Journal of the Chinese Chemical Society
  23. A Risky Business? Comparing the Harms of Alcohol and Other Recreational Drugs
    David Nutt · 2021 · Significance
  24. The risks of cannabis and other illicit drugs: Views among French and Finnish addiction treatment providers
    Laurence Simmat-Durand, Anja Koski‐Jännes · 2015 · The International Journal of Alcohol and Drug Research
  25. Synthetic cannabinoid: prevalence, mechanisms of addiction development, mental disorders associated with the use of synthetic cannabinoid
    Andrey Viktorovich Antsyborov, Vladimir Valerievich Mrykhin · 2017 · Interactive science
  26. Media portrayal of alcohol does not match its real harm effects in the Czech Republic
    Kateřina Zachová, Benjamin Petruželka, Miroslav Barták, Vladimír Rogalewicz · 2019 · Central European Journal of Public Health
  27. LEGAL THRESHOLDS FOR SERIOUS DRUG OFFENCES: EXPERT ADVICE TO THE ACT ON DETERMINING AMOUNTS FOR TRAFFICABLE, COMMERCIAL AND LARGE COMMERCIAL DRUG OFFENCES
    Caitlin Hughes, Alison J. Ritter · 2011
  28. Addiction and Lifestyles in Contemporary Europe: Reframing Addictions Project
    Alice Rap · 2014
  29. Hallucinogen Use in College Students: Current Trends and Consequences of Use
    Lena S. Jia, Jessica A. Gold · 2020 · Current Psychopharmacologye
  30. Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs
    Edward James, Thomas L Robertshaw, Michael J Pascoe, Fiona Chapman, Andrew D. Westwell, Andrew Paul Smith · 2019 · Drug Science Policy and Law
  31. Psychedelics and schizophrenia: A mystery in history
    Mark Haden, Birgitta Woods, Sarah A. Paschall · 2023 · Journal of Psychedelic Studies
  32. Návykové látky v české populaci mezi lety 2018-2023
    Ivana Olecká, Jiří Pospíšil · 2023
  33. Benefit-Risk Assessment of Statins (Lipid Lowering Agents): A Multi-Criteria Decision Analysis
    Tanatape Wanishayakorn, Surachat Ngorsuraches · 2015 · Journal of Multi-Criteria Decision Analysis
  34. Worries about others’ substance use—Differences between alcohol, cigarettes and illegal drugs?
    Inger Synnøve Moan, Elisabet Esbjerg Storvoll, Ingunn Olea Lund · 2017 · International Journal of Drug Policy
  35. Assessing the relationship between drug use initiation age and racial characteristics
    Diandian Yilin, Meghan Bellerose, Carson Borbely, Tawandra L. Rowell‐Cunsolo · 2023 · Journal of Ethnicity in Substance Abuse
  36. Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment
    Metten Somers, Floortje E. Scheepers · 2025 · American Journal of Psychiatry
  37. ¿Cuáles y qué tan graves son los daños a la salud individual y a la sociedad causados por el consumo de drogas lícitas e ilícitas?
    Tania Romo‐González, Carlos Larralde · 2013 · Psychologia
  38. Ethno-epidemiology of alcohol use among Zimbabwean migrants living in the UK
    Walter Dudzai Tasosa · 2018 · Sheffield Hallam University
  39. Graphene-Based Nanocomposites in Electrochemical Sensing
    Untika Pengsomjit, Fatima Alabdo, Waleed Alahmad, Pakorn Varanusupakul, Charoenkwan Kraiya · 2024 · Engineering materials
  40. Synthetische Cannabinoide: Verbreitung, Suchtbiologie & aktuelle Perspektive der persönlichen Gesundheitsgefährdung Synthetic Cannabinoids: Spread, Addiction Biology & Current Perspective of Personal Health Hazard
    Udo Bonnet, Hellmut Mahler, Klinik für Psychiatrie · 2015
  41. The Use of Psychoactive Substances and Illegal Drugs in the Albanian Society
    Linda Matua, Guido Muharremi, Elizana Petrela, Mirnela Koçibelli, Gentian Vyshka, Bledar Xhemali · 2018 · Current Drug Research Reviews
  42. Drug Laws, Ethics, and History
    Adam Greif · 2019 · Filozofia
  43. Pharmacotherapy for Cocaine Use Disorders
    Boris B. Quednow, Etna Engeli, Marcus Herdener · 2021 · Springer eBooks
  44. Consciousness alterations in a cohort of young Swiss men: Associations with substance use and personality traits
    Marianthi Lousiana Deligianni, Joseph Studer, Gerhard E. Gmel, Yasser Khazaal, Nicolas Bertholet · 2023 · Frontiers in Psychiatry
  45. Quantitative Assessment of High School Students’ Poly-drug Use: Related Social Aspects and School Dropout
    Carla Riva Rossi, Francesco Fabi, Emanuela Colasante, Sabrina Molinaro, Gianpaolo Scalia Tomba · 2023 · Current Drug Research Reviews
  46. Die Besteuerung gesundheitsschädlicher Produkte
    Salvatore Barbaro · 2024 · List Forum für Wirtschafts- und Finanzpolitik
  47. Middelengebruik en crimineel gedrag
    Maarten W.J. Koeter, Wim van den Brink · 2012 · Bohn Stafleu van Loghum eBooks
  48. Public health impact of substance use
    Viktor Mravčík, Pavla Chomynová, Kateřina Grohmannová · 2019 · Hygiena
  49. Psychedelics and Mental Health
    Angelica Milla · 2020 · NSUWorks (Nova Southeastern University)
  50. Heroinintoxikationen: Risikofaktoren zur Notfallanamnese aus Expertensicht
    Sven Oliver Schneider, Christian Richter, Rainer Niethammer, Larissa Beisel · 2020 · Notarzt
  51. Bia: Um Aplicativo de Redução de Danos Analítico-Comportamental
    Maxwell Cândido de Lima, Carolina Pedroza Barros da Silva, Roberto Soares Pessôa Neto, Daniely Ildegardes Brito Tatmatsu · 2022 · Perspectivas em Análise do Comportamento
  52. Psilocybin and Magic Mushrooms: Patterns of Abuse and Consequences of Recreational Misuse
    Andreia Machado Brito-da-Costa, Diana Dias da Silva, Áurea Madureira-Carvalho, Ricardo Jorge Dinis‐Oliveira · 2022 · Springer eBooks
  53. Development of New Indicators for Assessing the Level and Consequences of Drug Use: Applications and Comparisons
    Francesco Fabi, Carla Riva Rossi · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  54. Substance use and intimate partner violence: A meta-analysis
    Bryan M. Cafferky · 2015 · K-State Research Exchange (Kansas State University)
  55. Re: Debatten rundt cannabis
    Andreas Wahl Blomkvist, Fredrik Eika · 2017 · Tidsskrift for Den norske legeforening
  56. Harm Estimation from psychoactive drug use under MCDA principles and community perceptions in Colombia, 2021.
    Guillermo Alonso Castaño Pérez, Ells Natalia Galeano Gasca, Juan de Jesús Sandoval · 2022 · Research Square
  57. Measuring the harms of psychotropic substance use and poly-use in the nightlife scene: a pilot application of poly-drug use indicators on Italian data collected within the ALAMA study
    Francesco Fabi, Silvia Graziano, Elisa Benedetti, Sabrina Molinaro, Gianpaolo Scalia Tomba, Carla Rossi · 2023 · Qeios
  58. Modeling The Effects Of Substance Dependence On General Self-Reported Health Using Nominal Regression
    Taylor Moseley · 2020
  59. Sociological Testimony in Alcohol- and Other Drug-Associated Litigation
    Stephen J. Morewitz · 2013 · Springer eBooks
  60. For peer review only Quantifying the relative risk of harm to self and others from substance misuse - results from a national survey of experts.
    Nhs Lanarkshire · 2011
  61. L’alcool en questions
    Étienne Quertemont · 2015 · Mardaga eBooks
  62. I hvilken utstrekning rammer straffeloven § 231 befatning med narkotika ment til bruk i religiøs sammenheng?
    Øyvind Røed · 2015 · NORA - Norwegian Open Research Archives
  63. Analysis of different drug policy approaches and consequences
    L Di Censi, Francesco Fabi, Carla Riva Rossi · 2014 · Cineca Institutional Research Information System (Tor Vergata University)
  64. Legalisierung von Cannabis: zum laufenden Experiment mit der Bevölkerung
    Udo Bonnet · 2016 · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
  65. Acting on impulse: using the neuroscience of impulse control to improve the law
    Dylan Roskams-Edris · 2016 · Memorial University Research Repository (Memorial University)
  66. Re: Debatten rundt cannabis
    Andreas Wahl Blomkvist · 2017 · Tidsskrift for Den norske legeforening
  67. S.E. Olsen og medarbeidere svarer:
    Sofia E. Olsen, Michael Bretthauer, Mette Kalager · 2017 · Tidsskrift for Den norske legeforening
  68. Step Five: Broaden the Horizons of the Drug Policy Debate
    Caroline Chatwin · 2018 · Springer eBooks
  69. Contemplating the micro and macro of alcohol use and misuse to enable meta-understandings
    Ian P. Albery, Daniel Frings · 2021 · Elsevier eBooks
  70. Is Marijuana Safer than Alcohol? Insights from Users’ Self-Reports
    Jonathan P. Caulkins · 2018 · Figshare
  71. Normalisering van middelengebruik in Nederland
    Gjalt-Jorn Peters · 2019 · PsyArXiv (OSF Preprints)
  72. Facts Versus Fiction in Adolescent Substance Use: Implications for Public Health
    Melissa R. Schick, Tessa Nalven, Michael C. Crawford, Katelyn T. Kirk‐Provencher, Nichea S. Spillane · 2022 · Springer eBooks
  73. L'alcool en questions
    Étienne Quertemont · 2020 · Mardaga eBooks
  74. Psilocybe mexicana R. Heim – Mexikanischer Kahlkopf
    Antonia Kuhn, Matthias F. Melzig · 2022 · Zeitschrift für Phytotherapie
  75. Measuring Drug Harm
    2022 · Royal Society of Chemistry eBooks
  76. Vergleichende Risiko/Nutzen-Analyse verschiedener psychotroper Substanzen aus der Perspektive deutscher Drogenkonsumenten und Suchtmediziner – Ein Beitrag für die Psychoedukationsarbeit mit Abhängigkeitserkrankten und Restriktions-/Legalisierungsdebatten
    Ann-Kristin Kanti, Michael Specka, Norbert Scherbaum, Udo Bonnet · 2022 · Fortschritte der Neurologie · Psychiatrie
  77. Facts Versus Fiction in Adolescent Substance Use: Implications for Public Health
    Melissa R. Schick, Tessa Nalven, Michael C. Crawford, Katelyn T. Kirk‐Provencher, Nichea S. Spillane · 2022 · Springer eBooks
  78. Substance-specific readiness to change among sexual and gender minority men who use crystal methamphetamine
    Kiffer George Card, Madison McGuire, Jordan Bond‐Gorr, Tribesty Nguyen, Gordon A. Wells, Karyn Fulcher, Graham W. Berlin, Nathan J. Lachowsky · 2022 · Journal of Men s Health
  79. Experiencias psicodélicas: fenomenología, potenciales terapéuticos y modelos explicativos
    Tamara Chernoff, Bruno Kliger, Dante Hernán Venturini · 2023 · Vertex Revista Argentina de Psiquiatría
  80. Disruptive life events and health
    Lluís Mangot Sala · 2023 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  81. Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial
    Laetitia Vanderijst, Felix Hever, Anne Buot, Charles Dauré, Janaïna Benoit, Catherine Hanak, Johannes Veeser, Margot Morgiève, Salvatore Campanella, Charles Kornreich et al. · 2024 · Research Square
  82. Perceptions of the Seriousness of Different Addictive Behaviors in the United Kingdom
    John Alastair Cunningham, Jirapart Limaksorn · 2024 · Substance Use & Misuse
  83. “I knew where help was.” Identifying Substance Use Patterns, Associated Predictors of Harm, and Barriers to Help Seeking among Music Festival Attendees: The Development of a Targeted Harm Reduction Intervention
    Chloe L. Rayner · 2024 · Cronfa (Swansea University)
  84. Measuring The Harms Caused by Illicit Drugs. A New Methodology for Estimating Drug Harm Index
    Mohammad Hassan Novin, Emran Mohammad Razaghi, Farshad Farzadfar, Mohammad Jafar Tarokh, Mahtab Rouhifard · 2024 · Substance Use & Misuse
  85. Efficacy of Transcranial Magnetic Stimulation in Tobacco Abstinence Among Adult Tobacco Users Compared to Usual Care or no Treatment – A Systematic Review
    Rashmi Mehra, Karn Mehra · 2023 · Medical Journal of Dr D Y Patil Vidyapeeth
  86. Legalisierung, nicht Bagatellisierung
    Jakob Schlink, Artur Schroers · 2024 · Sozial Extra
  87. Substances psychoactives : politiques et responsabilité de l'État : le point de vue des Français
    Julie Camus · 2013 · theses.fr (ABES)
  88. Mindfulness et addictions : évaluation du programme MBRP (Mindfulness-Based Relapse Prevention) chez des patients présentant une addiction avec ou sans substance
    Cora von Hammerstein · 2018 · theses.fr (ABES)
  89. A profile of firearm-related fatalities admitted to the Diepkloof Forensic Pathology Service Soweto medico-legal mortuary during the COVID-19 and post COVID-19 periods
    I.J. Wainer, N. Mphaphuli, S. Holland · 2026 · International Journal of Injury Control and Safety Promotion
  90. Monitoring and assessing drug policies: scoring poly-drug use in the segments of the teenage population as a tool for cross country comparisons and economic evaluations. Preprint
    Francesco Fabi, Renato Pietro Ricci, Carla Rossi · 2012 · Cineca Institutional Research Information System (Tor Vergata University)
  91. Evidence-based pharmacotherapy of nicotine and alcohol dependence
    Wim van den Brink · 2012 · Cambridge University Press eBooks